Announcements Trials
Browse Landscape

Phase

Phase 2 4Phase 1/2 2Phase 4 1

Status

Completed 17Terminated 8Unknown 7Withdrawn 3Active not recruiting 3Recruiting 2

Sponsor Class

OTHER 7

Study Type

Interventional 7

Sponsor

Cancer Type

Other hematologic neoplasm 3Myeloid 2Thoracic 1Plasma cell 1

Conditions

Polycystic Ovary Syndrome 2Leukemia, Myelogenous, Chronic, BCR-ABL Positive 2Recurrence 1Multiple Myeloma 1Leukemia, Myeloid, Chronic-Phase 1Carcinoma, Non-Small-Cell Lung 1

Interventions

Cisplatin 504Cyclophosphamide 353Radiotherapy 349Carboplatin 347Capecitabine 328Oxaliplatin 319Paclitaxel 316Gemcitabine 315Docetaxel 308Fluorouracil 281apatinib 240Drug Therapy 239Bevacizumab 224camrelizumab 212Etoposide 199Irinotecan 176Doxorubicin 174Dexamethasone 159Leucovorin 158sintilimab 140Pemetrexed 136Cytarabine 136pembrolizumab 135anlotinib 135toripalimab 124S 1 (combination) 119Neoadjuvant Therapy 119Vincristine 118Rituximab 114Radiosurgery 113

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

7 trials
RecentStart dateEnrollment
Unknown × Interventional × Pioglitazone × Clear all
NCT05394142 2024-04-22

SPIOMET4HEALTH

Fundació Sant Joan de Déu

Phase 2 Unknown
364 enrolled

Polycystic Ovary Syndrome

NCT05519813 2022-08-29

Effects of Pioglitazone Combined With Metformin on Gonadal and Metabolic Profiles in Chinese Nonobese PCOS Patients.

Shengjing Hospital

Phase 4 Unknown
60 enrolled

Polycystic Ovary Syndrome

NCT02767063 2020-08-07

ACTIW

Versailles Hospital

Phase 1/2 Unknown
100 enrolled
Other hematologic neoplasm

Leukemia, Myeloid, Chronic-Phase

NCT02889003 2018-03-22

PIO2STOP

Versailles Hospital

Phase 2 Unknown
26 enrolled
MyeloidOther hematologic neoplasm

Leukemia, Myelogenous, Chronic, BCR-ABL Positive

NCT02852083 2018-01-18

ModuLung

University Hospital Regensburg

Phase 2 Unknown
86 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung

NCT02687425 2016-02-22

SESPI

Tongji Hospital

Phase 2 Unknown
20 enrolled
MyeloidOther hematologic neoplasm

Leukemia, Myelogenous, Chronic, BCR-ABL Positive

NCT01010243 2012-05-30

MM03

University of Regensburg

Phase 1/2 Unknown
54 enrolled
Plasma cell

Multiple Myeloma, Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon âš¡